Integra Lifesciences Holdings (IART) Total Debt (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Total Debt of $1.8 billion for Q2 2026, down 0.52% sequentially from $1.8 billion in Q1 2026, and up 5.14% YoY from $1.7 billion in Q2 2025.
Integra Lifesciences Holdings (IART) Total Debt (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Total Debt for 18 years, with the latest figure at $1.8 billion in Q2 2026.
- Quarterly Total Debt rose 5.14% year-over-year to $1.8 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.8 billion (up 5.14% YoY) and the FY2025 annual result came in at $1.8 billion, up 9.41% from the prior year.
- Total Debt fell to $1.8 billion in Q2 2026 per IART's latest filing, from $1.8 billion in the prior quarter.
- Over five years, Total Debt peaked at $1.8 billion in Q4 2025 and troughed at $837.8 million in Q4 2022.
- A 5-year average of $1.3 billion and a median of $1.2 billion in 2024 frame the typical range for Total Debt.
- The sharpest annual moves came in 2022 and 2024: Total Debt slipped 10.56% in 2022, then surged 84.14% in 2024.
- Over 5 years, Total Debt stood at $837.8 million in 2022, then climbed by 9.18% to $914.8 million in 2023, then surged by 81.59% to $1.7 billion in 2024, then increased by 9.41% to $1.8 billion in 2025, then dropped by 2.07% to $1.8 billion in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $1.8 billion, $1.8 billion, and $1.8 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 32.61 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.94 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 27.96 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 12.62 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.10 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.68 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.89 Bn |
| 10 | Integra Lifesciences Holdings | 1.28 Bn | 1.01 Bn | 219.74 Mn | 1.78 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.78 Bn |
| Mar 31, 2026 | 1.79 Bn |
| Dec 31, 2025 | 1.82 Bn |
| Sep 30, 2025 | 1.75 Bn |
| Jun 30, 2025 | 1.69 Bn |
| Mar 31, 2025 | 1.70 Bn |
| Dec 31, 2024 | 1.66 Bn |
| Sep 30, 2024 | 1.70 Bn |
| Jun 30, 2024 | 1.23 Bn |
| Mar 31, 2024 | 1.27 Bn |
| Dec 31, 2023 | 914.76 Mn |
| Sep 30, 2023 | 925.79 Mn |
| Jun 30, 2023 | 865.80 Mn |
| Mar 31, 2023 | 877.50 Mn |
| Dec 31, 2022 | 837.85 Mn |
| Sep 30, 2022 | 920.53 Mn |
| Jun 30, 2022 | 933.75 Mn |
| Mar 31, 2022 | 944.50 Mn |
| Dec 31, 2021 | 936.76 Mn |
| Sep 30, 2021 | 966.70 Mn |